Frank Santoro

As Chief Medical Officer, Frank oversees Synteract’s specialized Centers of Development and is responsible for setting strategic direction for all its medical affairs services. This includes building infrastructure and framework to further expand Synteract’s therapeutic, medical, and scientific capabilities, as well as overseeing staff involved in supporting client projects.

A CRO industry veteran with more than 30 years of experience in clinical research, Frank has served as a project physician for numerous domestic and international studies and has directed project team activities in the execution of Phase I-IV research programs. He has extensive experience managing global operations and has worked in virtually every therapeutic area, with considerable experience in oncology in particular.

Prior to joining Synteract, he served as Chief Medical Officer for Novella Clinical. Prior to that, he was Vice President, Clinical Development and Medical Affairs for Protherics, a UK-based biopharmaceutical company specializing in oncology and critical care products. Before Protherics, Frank spent 17 years in the CRO industry where he developed medical and clinical research capabilities to service clinical development programs.

Frank earned his medical degree from Ohio State University College of Medicine and his undergraduate degree from Miami University in Ohio.